tradingkey.logo
tradingkey.logo
Buscar

Nanovibronix Inc

NAOV
Añadir a la lista de seguimiento
4.020USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
3.17MCap. mercado
PérdidaP/E TTM

Más Datos de Nanovibronix Inc Compañía

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

Información de Nanovibronix Inc

Símbolo de cotizaciónNAOV
Nombre de la empresaNanovibronix Inc
Fecha de salida a bolsaApr 24, 2015
Director ejecutivoBesser (Doron)
Número de empleados15
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 24
Dirección969 Pruitt Piace
CiudadTYLER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75703
Teléfono19142333004
Sitio Webhttps://nanovibronix.com/
Símbolo de cotizaciónNAOV
Fecha de salida a bolsaApr 24, 2015
Director ejecutivoBesser (Doron)

Ejecutivos de Nanovibronix Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Nanovibronix Inc?

Los cinco principales accionistas de Nanovibronix Inc son: Dr. Harold Jacob, M.D.

¿Cuántas instituciones poseen acciones de Nanovibronix Inc (NAOV)?

A fecha de 2026Q1, 17 instituciones poseen acciones de Nanovibronix Inc, con un valor de mercado combinado de aproximadamente 44.60K, lo que representa el 1.21% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 33009.00.